GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News:
Capio AB (STO:CAPIO)
Certain members of Capio AB (publ)’s (”Capio”) group management, including its President and CEO, Thomas Berglund, and board of directors have acquired a total of 1,197,176 shares in Capio from its main shareholder, Ygeia Equity AB (“Ygeia”) (the “Transaction”). The shares were acquired at the prevailing market price. Following the Transaction and assuming that the over-allotment option granted to J.P. Morgan and SEB in the initial public offering and listing of Capio (the “IPO”) is fully exercised, Ygeia holds 84,608,473 shares, corresponding to 59.9% of the total number of shares in Capio.
J.P. Morgan and SEB have, in their capacity as Joint Global Coordinators and Joint Bookrunners in the IPO agreed to a waiver of the lock-up undertaking entered into by Ygeia in connection with the IPO, for the purposes of the Transaction. Ygeia will continue to be bound by the lock-up undertaking with respect to its remaining shareholding in Capio.
The board of Directors of Capio AB (publ).
 Ygeia Equity AB is owned by Nordic Capital Fund VI (“Nordic Capital”), the Apax Europe VI fund (advised by Apax Partners LLP) (“Apax Partners”) and the Apax France VII fund (managed by Apax Partners S.A, “Apax France”).
Capio AB (publ) is a leading, pan-European healthcare provider offering a broad range of high quality medical, surgical and psychiatric healthcare services in four countries through its hospitals, specialist clinics and primary care units. In 2014, Capio’s 12,357 employees provided healthcare services during 4.6 million patient visits across the Group’s facilities in Sweden, Norway, France and Germany, generating net sales of MSEK 13,200. Capio operates across three geographic segments: Nordic (54 percent of Group net sales 2014), France (37 percent of Group net sales 2014) and Germany (9 percent of Group net sales 2014). For more information about Capio, please see www.capio.com.
This information was brought to you by Cision http://news.cision.com